Mexico Oncology Drugs Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : February 2022
  • Region: Mexico
  • Country: Other
  • Report ID : 5066

  • Format: PPT, PDF

Mexico Oncology Drugs Market: Segmented by Therapy Type, and Cancer Type – Growth, Market Size, Future Prospects & Competitive Analysis, 2021 – 2028

Clear
SKU: 5066 Categories: ,

Report Description of the Mexico Oncology Drugs Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of Mexico Oncology Drugs Drugs market
  • To classify and forecast Mexico Oncology Drugs Market market based on application, drugs, project type, and application.
  • To identify drivers and challenges for Mexico Oncology Drugs market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in Mexico Oncology Drugs market
  • To conduct pricing analysis for Mexico Oncology Drugs Drugs market
  • To identify and analyze the profile of leading players operating in Mexico Oncology Drugs market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Atopic Dermatitis drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Atopic Dermatitis market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

Mexico Oncology Drugs Market Executive Summary

In Mexico, according to the Union for International Cancer Control (UICC), cancer is the third leading cause of death, and an estimated 128 000 new cases are detected each year, consequently leading to the growth of the market.

Market Size and Key Findings

The Mexico Oncology Drugs market size is at around USD xx billion in 2021 and is projected to reach USD xx billion in 2028, exhibiting a CAGR of xx% during the forecast period.

According to Globocan in Mexico,in the year of 2020 number of new cancer cases in both sex and all ages are Breast cancer (29,929), Prostrate cancer (26,742), Colorectum ( 14,901), Thyroid (11,27),Cervix uteri (9,439 and other cancers (103,261). Thus, the growing incidence and prevalence of cancer are likely to drive the growth of the Oncology market in Mexico during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

Increase in prevalence in cancer, growth in population and more dispatchable money with the older section of the society, and rise in awareness about the treatments, technologies, and the disease itself drive the market growth.

Nevertheless, advancements in cancer drug research owing to biological/targeted therapies and personalized medicines make way for promising opportunities for pharmaceutical, bio-pharmaceutical, and biotechnology companies engaged in developing cancer drugs.

Market Restraints

The high cost involved in new drug development coupled with threat of failure and adverse effects associated with anti-cancer drugs therapies restrain the growth of the market.

COVID-19 impact on “Mexico Oncology Drugs Market” 

Key players operating in the Latin America oncology devices market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials due to irregularities in transportation. Furthermore, distributors are experiencing irregular demand for products from the retailers due to rising incidence of COVID -19.

Competitive Landscape

Key Players

Key market players in Mexico Oncology Drugs market include Danaher Corp, Eiken Chemical Co Ltd, Qiagen NV, Quidel Corp, Hoffmann-La Roche Ltd, Novartis, Agilent Technologies Inc, Hemosure Inc and Others

Products in Pipeline

Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced new follow-up efficacy, safety and patient-reported outcomes (PROs) data from the Phase II CITYSCAPE trial, investigating the novel anti-TIGIT cancer immunotherapy tiragolumab plus Tecentriq® (atezolizumab) compared with Tecentriq alone as an initial (first-line) treatment for people with PD-L1-positive metastatic non-small cell lung cancer (NSCLC). The full results are being featured as an oral presentation in the Proffered Paper session 2 (Abstract LBA2) at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2021

Notable Recent Deals

December 2021 – Novartis has entered an option, partnership and licence agreement for BeiGene’s anti-cancer therapy, ociperlimab (BGB-A1217), bolstering its research and development works in immuno-oncology. Ociperlimab is a T Cell Immunoreceptor With Ig And ITIM Domains (TIGIT) inhibitor. According to the deal, BeiGene is entitled to receive $300m from Novartis as an upfront payment. If Novartis exercises the option before late 2023, BeiGene is also eligible for up to $700m.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of Mexico Oncology Drugs Services

In Mexico, while no reliable national estimates prior to Seguro Popular are available, an initial assessment of this policy found increasing coverage of childhood cancer care with an estimated survival of 50% for all. As Mexico’s current government restructures the health system and integration of non-communicable diseases to universal health coverage frameworks are considered for other countries, a comprehensive assessment of the health outcomes achieved under Mexico’s financing policy for high cost cancer treatments is warranted.

1. Report Description of the Mexico Oncology Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Mexico Oncology Drugs Market Executive Summary
2.1 Mexico Oncology Drugs Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Mexico Oncology Drugs Market
3.1 Market Growth Drivers Analysis
3.1.1 Increase in prevalence in cancer
3.1.2 Growth in population and dispatchable money
3.1.3 Rise in awareness about the treatments, technologies, and the disease
3.1.4 Advancements in cancer drug research
3.2 Market Restraints Analysis
3.3 High cost involved in new drug development
3.4 Adverse effects associated with anti-cancer drugs therapies
3.5 Covid-19 Market Impact Analysis
3.3.1 Negative impact on outcomes
4. Oncology Drugs Market Segmentation
4.1 By Therapy Type Analysis:
4.1.1 Chemotherapy
4.1.2 Immunotherapy
4.1.3 Target Therapy
4.1.4 Hormonal Therapy
4.1.5 Other Treatment Type
4.2 By Cancer Type Analysis:
4.2.1 Blood Cancer
4.2.2 Breast Cancer
4.2.3 Gastrointestinal Cancer
4.2.4 Respiratory/Lung Cancer
4.2.5 Skin Cancer
4.2.6 Other Cancer Types
5. Mexico Oncology Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Mexico Oncology Drugs Market
6.4 Notable recent deals in Mexico Oncology Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Danaher Corp Company Overview
Product & Services, Strategies & Financials
7.2 Eiken Chemical Co Ltd Company Overview
Product & Services, Strategies & Financials
7.3 Qiagen NV Company Overview
Product & Services, Strategies & Financials
7.4 Quidel Corp Company Overview
Product & Services, Strategies & Financials
7.5 Hoffmann-La Roche Ltd Company Overview
Product & Services, Strategies & Financials
7.6 Novartis Company Overview
Product & Services, Strategies & Financials
7.7 Agilent Technologies Inc. Company Overview
Product & Services, Strategies & Financials
7.8 Hemosure Inc Company Overview
Product & Services, Strategies & Financials
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of Mexico Oncology Drugs Market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development Mexico Oncology Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations

Oncology Drugs Market Segmentation

By Therapy Modality Type:

Availability of various advance oncology treatment such as targeted therapy and hormonal therapy among others will enhance the segment expansion.

  • Chemotherapy
  • Immunotherapy
  • Target Therapy
  • Hormonal Therapy
  • Other Therapy

By Cancer Type:

The cancer segment is expected to rise exponentially during the forecast period. The growing prevalence of cancer and rising awareness regarding therapeutics will boost the segment’s growth.

  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Respiratory/Lung Cancer
  • Skin Cancers
  • Other Cancers

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements